BACE2 variant identified from HSCR patient causes AD-like phenotypes in hPSC-derived brain organoids

Abstract β-site APP-cleaving enzyme 2 (BACE2) is a homolog of BACE1, which is considered as the most promising therapeutic target for Alzheimer’s disease (AD). However, the expression and functional role of BACE2 in central nervous system (CNS) remain obscured. Previously, we identified several BACE...

Full description

Bibliographic Details
Main Authors: Juan Luo, Hailin Zou, Yibo Guo, Ke Huang, Elly Sau-Wai Ngan, Peng Li
Format: Article
Language:English
Published: Nature Publishing Group 2022-02-01
Series:Cell Death Discovery
Online Access:https://doi.org/10.1038/s41420-022-00845-5
_version_ 1798023851625414656
author Juan Luo
Hailin Zou
Yibo Guo
Ke Huang
Elly Sau-Wai Ngan
Peng Li
author_facet Juan Luo
Hailin Zou
Yibo Guo
Ke Huang
Elly Sau-Wai Ngan
Peng Li
author_sort Juan Luo
collection DOAJ
description Abstract β-site APP-cleaving enzyme 2 (BACE2) is a homolog of BACE1, which is considered as the most promising therapeutic target for Alzheimer’s disease (AD). However, the expression and functional role of BACE2 in central nervous system (CNS) remain obscured. Previously, we identified several BACE2 rare variants in Hirschsprung disease (HSCR) patients and proved that BACE2-mediated APP cleavage might represent a novel HSCR pathogenesis mechanism in enteric nervous system. Here, we validated that these HSCR-associated BACE2 variants were loss-of-function mutations. Using the human pluripotent stem cell (hPSC)-derived brain organoids (BOs), we further demonstrated that BACE2 was mainly expressed in the ventricular zone and cortical plate of BOs, and its expression level was gradually increased along with the BO maturation. Functionally, we found that the BOs carrying the BACE2 loss-of-function mutation (BACE2 G446R ) showed greater apoptosis and increased levels of Aβ oligomers compared to the control BOs, resembling with the AD-associated phenotypes. All these phenotypes could be rescued via the removal of APP protein in BACE2 G446R BOs. Furthermore, rather than BACE2 G446R , BACE2 WT overexpression in BOs carrying the APP Swedish/Indiana mutations attenuated the AD-associated phenotypes, including Aβ accumulation and neuronal cell death. Taken together, our results unravel that BACE2 can protect the neuronal cell from apoptosis caused by Aβ accumulation, and the deficiency of BACE2-mediated APP cleavage may represent a common pathological mechanism for both HSCR and AD.
first_indexed 2024-04-11T17:53:13Z
format Article
id doaj.art-63accbef13334404804b8db41f612a6a
institution Directory Open Access Journal
issn 2058-7716
language English
last_indexed 2024-04-11T17:53:13Z
publishDate 2022-02-01
publisher Nature Publishing Group
record_format Article
series Cell Death Discovery
spelling doaj.art-63accbef13334404804b8db41f612a6a2022-12-22T04:11:00ZengNature Publishing GroupCell Death Discovery2058-77162022-02-01811810.1038/s41420-022-00845-5BACE2 variant identified from HSCR patient causes AD-like phenotypes in hPSC-derived brain organoidsJuan Luo0Hailin Zou1Yibo Guo2Ke Huang3Elly Sau-Wai Ngan4Peng Li5Scientific Research Center, The Seventh Affiliated Hospital of Sun Yat-sen UniversityScientific Research Center, The Seventh Affiliated Hospital of Sun Yat-sen UniversityScientific Research Center, The Seventh Affiliated Hospital of Sun Yat-sen UniversityScientific Research Center, The Seventh Affiliated Hospital of Sun Yat-sen UniversityDepartment of Surgery, Li Ka Shing Faculty of Medicine, University of Hong KongScientific Research Center, The Seventh Affiliated Hospital of Sun Yat-sen UniversityAbstract β-site APP-cleaving enzyme 2 (BACE2) is a homolog of BACE1, which is considered as the most promising therapeutic target for Alzheimer’s disease (AD). However, the expression and functional role of BACE2 in central nervous system (CNS) remain obscured. Previously, we identified several BACE2 rare variants in Hirschsprung disease (HSCR) patients and proved that BACE2-mediated APP cleavage might represent a novel HSCR pathogenesis mechanism in enteric nervous system. Here, we validated that these HSCR-associated BACE2 variants were loss-of-function mutations. Using the human pluripotent stem cell (hPSC)-derived brain organoids (BOs), we further demonstrated that BACE2 was mainly expressed in the ventricular zone and cortical plate of BOs, and its expression level was gradually increased along with the BO maturation. Functionally, we found that the BOs carrying the BACE2 loss-of-function mutation (BACE2 G446R ) showed greater apoptosis and increased levels of Aβ oligomers compared to the control BOs, resembling with the AD-associated phenotypes. All these phenotypes could be rescued via the removal of APP protein in BACE2 G446R BOs. Furthermore, rather than BACE2 G446R , BACE2 WT overexpression in BOs carrying the APP Swedish/Indiana mutations attenuated the AD-associated phenotypes, including Aβ accumulation and neuronal cell death. Taken together, our results unravel that BACE2 can protect the neuronal cell from apoptosis caused by Aβ accumulation, and the deficiency of BACE2-mediated APP cleavage may represent a common pathological mechanism for both HSCR and AD.https://doi.org/10.1038/s41420-022-00845-5
spellingShingle Juan Luo
Hailin Zou
Yibo Guo
Ke Huang
Elly Sau-Wai Ngan
Peng Li
BACE2 variant identified from HSCR patient causes AD-like phenotypes in hPSC-derived brain organoids
Cell Death Discovery
title BACE2 variant identified from HSCR patient causes AD-like phenotypes in hPSC-derived brain organoids
title_full BACE2 variant identified from HSCR patient causes AD-like phenotypes in hPSC-derived brain organoids
title_fullStr BACE2 variant identified from HSCR patient causes AD-like phenotypes in hPSC-derived brain organoids
title_full_unstemmed BACE2 variant identified from HSCR patient causes AD-like phenotypes in hPSC-derived brain organoids
title_short BACE2 variant identified from HSCR patient causes AD-like phenotypes in hPSC-derived brain organoids
title_sort bace2 variant identified from hscr patient causes ad like phenotypes in hpsc derived brain organoids
url https://doi.org/10.1038/s41420-022-00845-5
work_keys_str_mv AT juanluo bace2variantidentifiedfromhscrpatientcausesadlikephenotypesinhpscderivedbrainorganoids
AT hailinzou bace2variantidentifiedfromhscrpatientcausesadlikephenotypesinhpscderivedbrainorganoids
AT yiboguo bace2variantidentifiedfromhscrpatientcausesadlikephenotypesinhpscderivedbrainorganoids
AT kehuang bace2variantidentifiedfromhscrpatientcausesadlikephenotypesinhpscderivedbrainorganoids
AT ellysauwaingan bace2variantidentifiedfromhscrpatientcausesadlikephenotypesinhpscderivedbrainorganoids
AT pengli bace2variantidentifiedfromhscrpatientcausesadlikephenotypesinhpscderivedbrainorganoids